First Reported Cases of COVID-19-Associated Mucormycosis in Tunisia
Rim Khemakhem 1 , Ichrak Bougharriou 2 * , Nesrine Kallel 1 , Anis Bafoun 2 , Feten Mahmoudi 2 , Samy Kammoun 1
More Detail
1 Pulmonology Department, Hedi Chaker Hospital, University of Sfax, TUNISIA2 Covid Oxygen Unit, Military Field Hospital, University of Sfax, TUNISIA* Corresponding Author


COVID-19 infection is associated with several complications such as mucormycosis. We report, to the best of our knowledge, the first published cases of mucormycosis associated with severe COVID-19 infection in Tunisia. The first case was a diabetic, 68-year-old man, who presented a rhino-orbito-cerebral mucromycosis. The second case was a 37-year-old woman with a chronic renal failure hemodialysis stage and liver disease and who presented a rhino-sinuso-orbital mucormycosis. The diagnosis of mucormycosis was retained in both cases seven days after COVID-19 infection. Antifungal treatment was prescriped. Surgical treatment was not possible. Both cases died. We should think about mucormycosis in patients with COVID-19 infection and emergency medical and surgical treatment must be started to reduce mortality.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

ELECTR J MED DENT STUD, Volume 12, Issue 1, March 2022, Article No: em0097

Publication date: 06 Apr 2022

Article Views: 739

Article Downloads: 565

Open Access References How to cite this article